Concepedia

Vincent J. Kalish

VJ

22

Publications

2.6K

Citations

18

H-Index

1990

Active since

Affiliations

General Atomics (United States)(Current)

Guilford College

Agouron Institute

Novartis (Switzerland)

Eli Lilly (United States)

Vincent J. Kalish is an author at General Atomics (United States) specializing in pharmacology, drug discovery, and biochemistry.

Top concepts

Publications per year

1990–2005

22

Publications

22

Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex

Charles R. Kissinger, Hans E. Parge, Daniel R. Knighton et al. · Nature · 1995 · 760 citations

, , +9

Viracept (Nelfinavir Mesylate, AG1343):  A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease

Stephen W. Kaldor, Vincent J. Kalish, Jay F. Davies et al. · Journal of Medicinal Chemistry · 1997 · 617 citations · Full text

, , +17

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease

Amy K. Patick, Hongmei Mo, Martin Markowitz et al. · Antimicrobial Agents and Chemotherapy · 1996 · 209 citations · Full text

, , +14

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · PubMed · 2003 · 204 citations

Improved Procedure for the Reduction of N-Acyloxazolidinones

Thomas D. Penning, Stevan W. Djurić, Richard A. Haack et al. · Synthetic Communications · 1990 · 143 citations

, , +7

Rows per page

1–5 of 22